Biopharmaceutical classification system - Experimental model of the prediction of drug bioavailability

Biomeditsinskaya Khimiya

Volumn 54, Issue 4, 2008, Pages 392-407

  Golovenko, N Ya ^a,b   Borisyuk, I Yu ^a  

^a A V BOGATSKY PHYSICO CHEMICAL INSTITUTE   (Ukraine)

^b Ministry of Health of Ukraine   (Ukraine)

Author keywords

Bioavailability; Biopharmaceutical classification system (BCS); Generic drug

Indexed keywords

EID: 56049121275     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Russian source
2. Russian source
3. Kennedy T. (1997) DDT. 2, 436-444.
4. Abrahamsson B., Lennernas N. (2003) in: Drug bioavailability WILEY, VCH, pp. 495-531.
5. Russian source
6. Russian source
7. Norinder U., Haeberlein M. (2003) in: Drug bioavailability WILEY, VCH, pp. 358-405.
8. Lipinski C., Lombardo E., Dominy B., Feeney P. (2001) Adv. Drug Deliv. Rev., 46, 3-26.
9. Lipinski C. (2003) DDT, 8, 12-16.
10. Amidon G., Lennernas H., Shah V., Crison J. (1995) Pharm. Res., 12, 413-420.
11. Macheras P., Dokoumetzidis A. (2000) Pharm. Res., 17, 108-112.
12. Granero C., Ramachandran C., Amidon G. (2003) in: Drug bioavailability WILEY, VCH, pp. 191-214.
13. Avdeff A. (1996) in: Lipophility in drug action and toxicology VCH, Weinheim, pp. 109-137.
14. Dressman J., Amidon G., Fleisher D. (1985) J. Pharm. Sci., 74, 588-589.
15. Yu L, Amidon G. (1999) Int. J. Pharm., 186, 119-125.
16. Lobenberg R., Amidon G.L. (2000) Eur. J. Pharm. Biopharm., 50, 3-12.
17. Johnson K., Swindell A. (1996) Pharma. Res., 13(12), 1795-1798.
18. Friend D. (2004) Current gastroenterology report, 6, 371-376.
19. Aungst B.I., Saitoh H. (1996) Pharm. Res., 13, 114-119.
20. Lennernas H. (1995) Pharm. Res., 12, 1573-1582.
21. Wu C., Benet L. (2005) Pharm. Res., 22(1), 11-23.
22. Ammins C., Jacobsen W., Benet L. (2005) J. Pharmacol. Exper. Ther., 300(3), 1036-1045.
23. Benet L, Oie S., Schwarz S. (1996) in: Pharmacological basis of therapeutics, 9-th edition, Mc Graw Hill, N. Y, pp. 1707-1792.
24. Rinaki E., Valsami G., Macheras P. (2003) Pharm. Res., 20, 1917-1925.
25. Yu L., Amidon G.L., Polli G. et al. (2002) Pharm. Res., 19, 921-925.
26. Yazdanian M., Briggs K., Yankovsky K., Hawi X. (2004) Drug Pharm. Res., 21, 293-297.
27. Yohel M. (2003) Dissolution Technologies, 10, 16-20.